<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03786965</url>
  </required_header>
  <id_info>
    <org_study_id>â„–22/18-H</org_study_id>
    <nct_id>NCT03786965</nct_id>
  </id_info>
  <brief_title>Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures.</brief_title>
  <acronym>MPO-CSP</acronym>
  <official_title>Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objection is to investigate molecular biology of myocardial damage during cardiac
      surgery procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess outcomes after cardiac surgery procedures. To investigate serum level of
      myeloperoxidase, morphology of left atrium appendage, to perform genetic analysis and cell
      biology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Anticipated">December 20, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death within 30 days after procedure.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Death within 30 days after surgical procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute myocardial infarction.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Acute myocardial infarction (ST-changes with troponin I &gt; 10 ng/ml).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Stroke (MRI changes or corresponding neurologist record).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arrhythmia</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Any type of arrhythmia including AV-block.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal dysfunction.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Renal dysfunction if serum creatinine greater than 25% of upper reference range.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infection or febrile.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Infection or febrile (t&gt; 37 or CRP elevation or long regeneration of surgical wound).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory dysfunction.</measure>
    <time_frame>within 30 days after procedure.</time_frame>
    <description>Respiratory dysfunction (pulmonary ventilation longer than 2 days).</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Cardiac Procedure Complication</condition>
  <condition>Ischemic Heart Disease</condition>
  <condition>Valve Heart Disease</condition>
  <condition>Defect Septal</condition>
  <arm_group>
    <arm_group_label>On-pump CABG.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>On-pump CABG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Off-pump CABG.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Off-pump CABG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pump-assisted CABG.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pump-assisted CABG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Valve Procedure without CABG.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heart Valve Procedure without CABG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Valve Procedure with CABG.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heart Valve Procedure with CABG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>On-pump CABG</intervention_name>
    <description>On-pump CABG</description>
    <arm_group_label>On-pump CABG.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Off-pump CABG</intervention_name>
    <description>Off-pump CABG</description>
    <arm_group_label>Off-pump CABG.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pump-assisted CABG</intervention_name>
    <description>Pump-assisted CABG</description>
    <arm_group_label>Pump-assisted CABG.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Valve Repair Procedure without CABG.</intervention_name>
    <description>Valve Repair Procedure without CABG (open heart procedure).</description>
    <arm_group_label>Heart Valve Procedure without CABG.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Valve Repair Procedure with CABG.</intervention_name>
    <description>Valve Repair Procedure with CABG (open heart procedure).</description>
    <arm_group_label>Heart Valve Procedure with CABG.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ischemic heart disease with indications for operation

          -  valve disease with indications for operation

          -  ischemic heart disease combined with valve disease with indications for operation

        Exclusion Criteria:

          -  patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Nemkov, PhD</last_name>
    <role>Study Director</role>
    <affiliation>First Saint-Petersburg Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Nemkov, PhD</last_name>
    <phone>+7-921-795-00-47</phone>
    <email>nemk_as@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimir Komok, PhD</last_name>
    <phone>+7-904-632-19-00</phone>
    <email>vladimir_komok@mail.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nikolai Bunenkov</name>
      <address>
        <city>Saint-Petersburg</city>
        <state>Non-US/Non-Canadian</state>
        <zip>194358</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolay Bunenkov</last_name>
      <phone>+7-950-028-17-40</phone>
      <email>bunenkov2006@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vladimir V Komok, Ph.D</last_name>
      <phone>+7 904 632 19 00</phone>
      <email>vladimir_komok@mail.ru</email>
    </contact_backup>
    <investigator>
      <last_name>Nikolai S Bunenkov</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleksey V Sokolov, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>December 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2018</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Petersburg State Pavlov Medical University</investigator_affiliation>
    <investigator_full_name>Aleksandr Nemkov</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Ischemic Heart Disease</keyword>
  <keyword>Valve Disease</keyword>
  <keyword>Septal Defect</keyword>
  <keyword>Myeloperoxidase</keyword>
  <keyword>Molecular biology</keyword>
  <keyword>Gene analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data are confidential.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

